These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11028144)

  • 1. Health technology assessment in Canada. A decade in review.
    Menon D; Topfer LA
    Int J Technol Assess Health Care; 2000; 16(3):896-902. PubMed ID: 11028144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining health technology assessment in Canada: diversification of products and contextualization of findings.
    Lehoux P; Tailliez S; Denis JL; Hivon M
    Int J Technol Assess Health Care; 2004; 20(3):325-36. PubMed ID: 15446762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia.
    Ball G; Levine MAH; Thabane L; Tarride JE
    Curr Oncol; 2022 Oct; 29(10):7624-7636. PubMed ID: 36290879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissemination of health technology assessments: identifying the visions guiding an evolving policy innovation in Canada.
    Lehoux P; Denis JL; Tailliez S; Hivon M
    J Health Polit Policy Law; 2005 Aug; 30(4):603-41. PubMed ID: 16318164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEALTH TECHNOLOGY ASSESSMENT EVIDENCE ON E-HEALTH/M-HEALTH TECHNOLOGIES: EVALUATING THE TRANSPARENCY AND THOROUGHNESS.
    Vukovic V; Favaretti C; Ricciardi W; de Waure C
    Int J Technol Assess Health Care; 2018 Jan; 34(1):87-96. PubMed ID: 29455685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPACT OF HEALTH TECHNOLOGY ASSESSMENT REPORTS ON HOSPITAL DECISION MAKERS - 10-YEAR INSIGHT FROM A HOSPITAL UNIT IN SHERBROOKE, CANADA: IMPACT OF HEALTH TECHNOLOGY ASSESSMENT ON HOSPITAL DECISIONS.
    Poder TG; Bellemare CA; Bédard SK; Fisette JF; Dagenais P
    Int J Technol Assess Health Care; 2018 Jan; 34(4):393-399. PubMed ID: 30021663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.
    Mathes T; Jacobs E; Morfeld JC; Pieper D
    BMC Health Serv Res; 2013 Sep; 13():371. PubMed ID: 24079858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries.
    Wang Y; Qiu T; Zhou J; Francois C; Toumi M
    Appl Health Econ Health Policy; 2021 May; 19(3):281-304. PubMed ID: 33426626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the quality of health technology assessment reports in a developing country.
    Sabermahani A; Yazdi-Feyzabadi V; Bashzar S
    East Mediterr Health J; 2023 Jul; 29(7):554-561. PubMed ID: 37553743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-ordinating health technology assessment in Canada: a European perspective.
    McDaid D
    Health Policy; 2003 Feb; 63(2):205-13. PubMed ID: 12543533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics in Canadian health technology assessment: a descriptive review.
    DeJean D; Giacomini M; Schwartz L; Miller FA
    Int J Technol Assess Health Care; 2009 Oct; 25(4):463-9. PubMed ID: 19845976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines.
    Grigore B; Ciani O; Dams F; Federici C; de Groot S; Möllenkamp M; Rabbe S; Shatrov K; Zemplenyi A; Taylor RS
    Pharmacoeconomics; 2020 Oct; 38(10):1055-1070. PubMed ID: 32572825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime.
    Miller FA; Lehoux P; Rac VE; Bytautas JP; Krahn M; Peacock S
    Soc Sci Med; 2020 Nov; 265():113528. PubMed ID: 33261901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.